Harbour grants Eli Lilly non-exclusive rights to discover and develop human therapeutic antibodies using Harbour's transgenic mouse platform

Harbour Antibodies B.V.

the Netherlands / Tools, Services, and Manufacturing

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Eli Lilly and Co.

U.S. / Large-Cap Biopharma (>=$50 billion)

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced